Vaccinex Files to Sell 193,000 Shares of Common Stock for Holders
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersProcessa Pharma (NASDAQ:PCSA) shares moved upwards by 31.2% to $2.12 during Thursday's pre-market session. The company's market cap stands at $6.0 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC
Vaccinex(VCNX.US) 10% Shareholder Buys US$1,333.86 in Common Stock
$Vaccinex(VCNX.US)$ 10% Shareholder FRIEDBERG ALBERT purchased 282 shares of common stock on Apr 19, 2024 at an average price of $4.73 for a total value of $1,333.86. This transaction involves other r
Vaccinex Faces Nasdaq Compliance Challenge
Vaccinex Q4 EPS $(0.33) Up From $(23.10) YoY
Vaccinex (NASDAQ:VCNX) reported quarterly losses of $(0.33) per share. This is a 98.57 percent increase over losses of $(23.10) per share from the same period last year.
Vaccinex Files to Sell 433.5K Common Shares for Holders
Vaccinex Reports Q4 Results
Vaccinex Expects Topline Data For Phase 1/2a Randomized SIGNAL-AD Study Of Pepinemab For Alzheimer's Disease In Q3 2024
Vaccinex Expects Topline Data For Phase 1/2a Randomized SIGNAL-AD Study Of Pepinemab For Alzheimer's Disease In Q3 2024
Vaccinex FY23 EPS $(43.68) Up From $(98.05) YoY, Revenue $570K Up From $275K YoY
Vaccinex FY23 EPS $(43.68) Up From $(98.05) YoY, Revenue $570K Up From $275K YoY
Vaccinex 2023 Rev $570,000 >VCNX
Vaccinex 2023 Rev $570,000 >VCNX
Press Release: Vaccinex Reports 2023 Financial Results and Provides Corporate Update
Vaccinex Reports 2023 Financial Results and Provides Corporate Update Expect Topline Data for Phase 1/2a Randomized SIGNAL-AD Study of Pepinemab for Alzheimer's Disease in Q3 2024 Company raised $17
Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
ROCHESTER, N.Y., March 27, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (NASDAQ:VCNX) ("Vaccinex" or the "Company"), a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer's
Vaccinex CFO Scott Royer to Retire, Jill Sanchez Steps in
Sector Update: Health Care Stocks Slipping Wednesday Afternoon
Health care stocks were easing Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both down about 0.4%. The iShares Biotechnology ETF (IBB) fell 0.3
Vaccinex Shares Rise as Company Announces Eight New Deals for Antibody Discovery Platform
Vaccinex (VCNX) shares rose 9.3% in recent trading Wednesday after the biotech company announced eight new agreements allowing the use of its proprietary ActivMAb platform in discovering antibodies ag
Teladoc Health, Avinger Among Healthcare Movers
Vaccinex Announces Multiple New Agreements for Access to ActivMAb Antigen Virus Technology
Eight new antibody discovery agreements incorporate Vaccinex's powerful ActivMAb Drug Discovery Platform ActivMab platform enables the discovery and development of high value antibodies against challe
Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Vaccinex To Carry Out 1-for-14 Reverse Stock Split On February 20th, 2024
February 16th - $Vaccinex(VCNX.US)$ is about to implement a 1-for-14 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from February 20th, 2024.$Vaccinex(VCNX.US)$
No Data